By Topic

Discrimination between alzheimer's disease and control group in MR-images based on texture analysis using artificial neural network

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$33 $13
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

3 Author(s)
Meysam Torabi ; Sharif Univ. of Technol., Tehran ; Reza Dehestani Ardekani ; Emad Fatemizadeh

In this study, we have proposed a novel method investigates MR-Images for normal and abnormal brains which effected by Alzheimer's Disease (AD) to extract 336 number of different features based on texture analysis. Before applying this algorithm, we have to use a registration method because of variety in size of normal and abnormal images. Consequently, the output of Texture Analysis System (TAS) is a vector containing 336 elements that are features extracted from texture. This vector is considered as the input of the Artificial Neural Network (ANN) which is feed-forward one. The features extracted from the Gray-level Co-occurrence Matrix (GLCM) have been interpreted and compared with normal brains to make the final decision. Decision making is the role of feed-forward ANN. Before using ANN, we have applied Principle Component Analysis (PCA) to eliminate any redundancies in features i.e. input vector. The results show a powerful diagnosis of AD with 95 percent proper response. Dataset includes 75 MR-images: 50 images show normal brains and rest of them is affected by AD. We used 60 percent of every group for training and 40 percent were considered as a "test data".

Published in:

2006 International Conference on Biomedical and Pharmaceutical Engineering

Date of Conference:

11-14 Dec. 2006